 | Up a level |
Andalucía, Carmen; Martínez-Prat, Laura; Bentow, Chelsea; Aure, Mary Ann; Horn, Michael P; Mahler, Michael (2023). Clinical Validity of Anti-Proteinase 3 Antibodies in Patients with Inflammatory Bowel Disease: A Short Meta-Analysis. Diagnostics, 13(24) MDPI 10.3390/diagnostics13243682
Horn, Michael P; Nagler, Michael (2022). [CME: Rational Laboratory Diagnostics in the Context of COVID-19]. Praxis, 111(11), pp. 592-596. Hogrefe 10.1024/1661-8157/a003881
Horn, Michael P; Jonsdottir, Hulda R; Brigger, Daniel; Damonti, Lauro; Suter-Riniker, Franziska; Endrich, Olga; Froehlich, Tanja K; Fiedler, Martin; Largiadèr, Carlo R; Marschall, Jonas; Weber, Benjamin; Eggel, Alexander; Nagler, Michael (2022). Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy, 77(7), pp. 2090-2103. Wiley 10.1111/all.15206
Sidler, Daniel; Born, Alexander; Schietzel, Simeon; Horn, Michael P; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Jafari, S Morteza Seyed; Radonjic-Hoesli, Susanne; Chan, Andrew; Hoepner, Robert; Bacher, Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Suter-Riniker, Franziska; Staehelin, Cornelia; ... (2022). Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy. RMD open, 8(1) BMJ Publishing Group 10.1136/rmdopen-2021-002166
Kolev, Mirjam; Horn, Michael P; Semmo, Nasser; Nagler, Michael (2022). Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers. Journal of translational autoimmunity, 5, p. 100151. Elsevier 10.1016/j.jtauto.2022.100151
Bitzenhofer, Michaela; Suter-Riniker, Franziska; Moor, Matthias B; Sidler, Daniel; Horn, Michael P; Gschwend, Anna; Staehelin, Cornelia; Rauch, Andri; Helbling, Arthur; Jörg, Lukas (2022). Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease. PLoS ONE, 17(6), e0268780. Public Library of Science 10.1371/journal.pone.0268780
Horn, Michael P; Zuercher, Adrian W; Imboden, Martin A; Rudolf, Michael P; Lazar, Hedvika; Wu, Hong; Hoiby, Niels; Fas, Stefanie C; Lang, Alois B (2010). Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. Antimicrobial agents and chemotherapy, 54(6), pp. 2338-44. Washington, D.C.: American Society for Microbiology 10.1128/AAC.01142-09
Lazar, Hedvika; Horn, Michael P; Zuercher, Adrian W; Imboden, Martin A; Durrer, Peter; Seiberling, Michael; Pokorny, Rolf; Hammer, Christophe; Lang, Alois B (2009). Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers. Antimicrobial agents and chemotherapy, 53(8), pp. 3442-6. Washington, D.C.: American Society for Microbiology 10.1128/AAC.01699-08
Favre, Didier; Lüdi, Stefan; Stoffel, Michael Hubert; Frey, Joachim; Horn, Michael P; Dietrich, Guido; Spreng, Simone; Viret, Jean-François (2006). Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae. Vaccine, 24(20), pp. 4354-68. Amsterdam: Elsevier 10.1016/j.vaccine.2006.02.052
Zuercher, Adrian W; Horn, Michael P; Que, John U; Ruedeberg, Anna; Schoeni, Martin H; Schaad, Urs B; Marcus, Paul; Lang, Alois B (2006). Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS immunology and medical microbiology, 47(2), pp. 302-8. Oxford: Blackwell 10.1111/j.1574-695X.2006.00103.x
Pachlopnik, Jana M; Horn, Michael P; Fux, Michaela; Dahinden, Markus; Mandallaz, Michèle; Schneeberger, Dominique; Baldi, Lucia; Vogel, Monique; Stadler, Beda M; Miescher, Sylvia M (2004). Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. Journal of autoimmunity, 22(1), pp. 43-51. Elsevier 10.1016/j.jaut.2003.09.007
